| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 137.73M | 177.90M | 255.10M | 229.60M | 57.10M |
| Gross Profit | 31.34M | 51.20M | 75.10M | 149.20M | 20.80M |
| EBITDA | 7.35M | 116.30M | 41.70M | 3.30M | 950.40M |
| Net Income | 19.40M | 10.60M | -144.00M | -67.10M | 894.50M |
Balance Sheet | |||||
| Total Assets | 513.19M | 619.70M | 667.60M | 1.53B | 2.25B |
| Cash, Cash Equivalents and Short-Term Investments | 132.75M | 123.40M | 189.50M | 891.20M | 400.70M |
| Total Debt | 16.01M | 105.40M | 119.20M | 162.90M | 180.70M |
| Total Liabilities | 139.75M | 270.40M | 261.10M | 341.40M | 447.80M |
| Stockholders Equity | 373.44M | 349.30M | 406.50M | 1.12B | 1.80B |
Cash Flow | |||||
| Free Cash Flow | 68.00M | 44.50M | -100.80M | -10.40M | 153.00M |
| Operating Cash Flow | 146.31M | 86.10M | -39.90M | 63.50M | 179.90M |
| Investing Cash Flow | -62.38M | -51.30M | 120.80M | 963.90M | -296.00M |
| Financing Cash Flow | -74.94M | -97.30M | -646.20M | -579.60M | -147.90M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £116.34M | -17.40 | 1.89% | 6.46% | -9.43% | ― | |
71 Outperform | £230.53M | 9.29 | 0.66% | ― | -32.66% | 72.67% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
56 Neutral | £368.34M | 166.34 | 0.54% | 4.36% | -18.05% | -634.88% | |
56 Neutral | £189.69M | -1.99 | 57.02% | ― | -32.47% | -1490.91% | |
50 Neutral | £142.90M | -24.27 | -11.54% | ― | -0.20% | -25.68% | |
44 Neutral | £203.64M | -3.20 | -136.50% | ― | -16.87% | 21.18% |